Arts

Books

Fashion & Beauty

Performing Arts

Food

Visual Arts

Design

Business

Entrepreneurship

Investing

Marketing

Careers

Management

Non-Profit

Comedy

Stand-Up

Comedy Interviews

Improv

Education

Self-Improvement

How To

Courses

Language Learning

Fiction

Comedy Fiction

Drama

Science Fiction

Government

Health & Fitness

Medicine

Alternative Health

Nutrition

Mental Health

Fitness

Sexuality

History

Kids & Family

Parenting

Stories for Kids

Education for Kids

Pets & Animals

Leisure

Video Games

Games

Automotive

Animation & Manga

Hobbies

Aviation

Home & Garden

Crafts

Music

Music Commentary

Music Interviews

Music History

News

Sports News

Entertainment News

News Commentary

Politics

Daily News

Business News

Tech News

Religion & Spirituality

Christianity

Spirituality

Religion

Judaism

Islam

Buddhism

Hinduism

Science

Social Sciences

Life Sciences

Natural Sciences

Nature

Chemistry

Mathematics

Earth Sciences

Physics

Astronomy

Society & Culture

Documentary

Relationships

Philosophy

Personal Journals

Places & Travel

Sports

Golf

Soccer

Wrestling

Basketball

Football

Fantasy Sports

Baseball

Wilderness

Running

Hockey

Rugby

Cricket

Volleyball

Tennis

Swimming

Technology

True Crime

TV & Film

Film Interviews

TV Reviews

After Shows

Film Reviews

Film History

Welcome to ALD Stories, a series of conversations where we share the untold stories of atomic layer deposition and the people behind the technology.

ALD stories podcast

Preclase química

TEMA DUREZA

Podcast é um conteúdo em áudio, disponibilizado através de um arquivo, que conta com a vantagem de ser escutado quando o usuário desejar. Pode ser ouvido em diversos dispositivos e costuma abordar um assunto específico.

Esses podcasts foram desenvolvidos para o ensino da matéria de soluções. O aluno deverá começar o processo de aprendizagem a partir do primeiro episódio de introdução do conteúdo, para que possa ter uma base, e em seguida o educando poderá ter a liberdade de assistir qualquer outro episódio fora da ordem.

Podcast é um conteúdo em áudio, disponibilizado através de um arquivo, que conta com a vantagem de ser escutado quando o usuário desejar. Pode ser ouvido em diversos dispositivos e costuma abordar um assunto específico. Esses podcasts foram desenvolvidos para o ensino da matéria de soluções. O aluno deverá começar o processo de aprendizagem a partir do primeiro episódio de introdução do conteúdo, para que possa ter uma base, e em seguida o educando poderá ter a liberdade de assistir qualquer outro episódio fora da ordem.

Podcast- PRÉ-ENEM QUÍMICA E FÍSICA 2023

Sobreviviendo a la COVID-19 en México, el remedio olvidado

Di sini aku akan berbagi tentang apapun itu hal-hal positif yang bisa dibagikan ke banyak orang

Jeda...

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA Therapy

First Feast Forensics - Episode 1: The Reality Behind the First Thanksgiving Menu Welcome to First Feast Forensics. Today we're peeling back the layers of history to uncover what was actually served at the first Thanksgiving celebration in 1621. Most of what we think we know about this famous feast comes from just two primary sources - a letter by Edward Winslow and a passage in William Bradford's Of Plymouth Plantation. These sparse historical records paint a very different picture from our modern celebrations, and over the next thirty minutes, we'll explore exactly what that three-day feast would have looked like, from the ecological context to the cooking methods used. To understand the first Thanksgiving meal, we need to first understand Plymouth in 1621. The settlement sat in a region previously occupied by the Patuxet people, who had been devastated by disease just a few years before. The landscape was a mix of cleared fields, forest, and coastal areas. This diverse environment provided a wealth of food sources that would have been utilized during the celebration. According to Winslow's firsthand account written in December 1621, four settlers went on a "fowling" mission in preparation for the feast. Let's explore what this actually meant. The term "fowling" refers to hunting wild birds, but the techniques used were far different from modern hunting. The settlers would have used matchlock muskets, which were notoriously unreliable in New England's damp climate. They also employed techniques learned from the Wampanoag, such as net trapping and using calls to lure birds. The waters around Plymouth were rich with waterfowl - ducks, geese, and even now-extinct passenger pigeons would have been abundant. These passenger pigeons, which would later be hunted to extinction by the late 1800s, were described by colonists as so numerous that they would darken the sky for hours when migrating. They were prized for their meat and were likely a significant part of the feast. If turkey was served, it would have been wild, not domesticated, and significantly different from our modern birds. Wild turkeys of the period were smaller, leaner, and more agile than their domestic counterparts. They were also more challenging to hunt, requiring knowledge of their habits and habitat. The Wampanoag had developed sophisticated hunting techniques for these birds, including the use of calls and decoys made from preserved turkey parts. The documented centerpiece of this historic meal was venison. Winslow records that the Wampanoag, led by Massasoit, arrived with five deer as their contribution to the feast. This wasn't just food - it was a profound diplomatic gesture. In both English and Wampanoag cultures, the sharing of venison carried deep significance. In English tradition, venison was often reserved for the nobility, while in Wampanoag culture, the sharing of deer meat represented respect and alliance. The hunting of these deer would have employed techniques refined over thousands of years. The Wampanoag used sophisticated driving techniques, where groups of hunters would coordinate to guide deer toward waiting hunters. They also used specialized weapons including bows and arrows with stone points specifically designed for large game. Archaeological evidence from the period shows these points were crafted with remarkable precision. The coastal location of Plymouth meant seafood played a crucial role in the celebration, though this part of the story is often overlooked in modern retellings. The colonists and Wampanoag regularly harvested shellfish from the nearby waters. Archaeological evidence from colonial middens (trash heaps) shows abundant shells from soft-shell clams, mussels, and oysters. These shellfish were not just gathered haphazardly - both cultures had developed sophisticated understanding of tidal patterns and seasonal availability. The collection of shellfish was often the work of women and children in both cultures. They used specialized tools including rakes and baskets designed specifically for this purpose. The timing of collection was crucial - both cultures understood the relationship between moon phases, tides, and shellfish safety. They also knew which areas produced the best specimens and how to ensure sustainable harvesting. Lobsters, which we now consider a luxury, were incredibly abundant. Historical records suggest they would wash up on shore in piles up to two feet high during storms. They were so plentiful that they were sometimes used as fish bait or fertilizer. The method of preparing lobster was different too - they were often dried and smoked rather than boiled fresh. Fish like cod and bass were dietary staples, caught using both English and Native American methods. The Wampanoag had developed sophisticated fish weirs - permanent underwater traps made from wooden stakes and woven reeds. These structures would trap fish during tidal changes while allowing smaller fish to escape, ensuring sustainable harvesting. The English brought their own fishing techniques, including hook and line fishing with metal hooks. Eels, now rarely seen on American tables, were particularly prized by both cultures. They were caught using specialized traps placed in tidal pools and streams. The Wampanoag had developed eel pots - woven baskets designed to trap eels while allowing water to flow through. These were so effective that the design was quickly adopted by the English settlers. What's particularly fascinating about the first Thanksgiving is not just what was present, but what was absent. Modern archaeological techniques, combined with careful study of colonial records, have given us a clear picture of what couldn't have been on the menu. Potatoes, both white and sweet, were still unknown in the region. White potatoes, originally from South America, were still viewed with suspicion by many Europeans. Sweet potatoes, despite being established in Spanish colonies, hadn't yet made their way to New England. The absence of sugar shaped the feast significantly. While cranberries were abundant in the region, and the Wampanoag used them for food and medicine, the sauce we know today would have been impossible without sugar. The Wampanoag traditionally used cranberries both fresh and dried, often combining them with dried meat to make pemmican - a concentrated survival food that could last for months. The pumpkin and squash preparations would have been completely different from our modern dishes. While these vegetables were available - the settlers called all squash "pompions" - they weren't made into pies. Without wheat flour, refined sugar, or proper ovens, pie-making was impossible. Instead, these gourds were probably prepared using a method described in period documents: the squash would be cut into strips, stewed until tender, and then served with butter and spices, or dried for winter storage. The grain situation at the first Thanksgiving reflects a fascinating cultural exchange. Corn was central to the feast, but this wasn't the sweet corn we enjoy today. The varieties grown were primarily flint corn, with hard kernels that could be dried and ground into meal. The Wampanoag had developed sophisticated cultivation techniques, including the famous Three Sisters method of planting corn, beans, and squash together. This agricultural system was more than just efficient farming - it was a sophisticated understanding of plant relationships that provided complete nutrition. The settlers had attempted to grow English grains, but with limited success. Barley and peas grew adequately, but wheat largely failed in New England's climate and soil. The colonists had to adapt their traditional recipes to use corn meal instead of wheat flour. This led to hybrid dishes - English cooking techniques applied to Native American ingredients. They would have made what they called "samp" - corn pounded into a coarse meal and boiled, often with pieces of meat or fish added. The wild edibles available in the area played a crucial role in the feast. The forest provided chestnuts, walnuts, and beechnuts, all of which would have been gathered in large quantities. Ground nuts (Apios americana), which grow wild in the region, were another important food source. These small tubers are high in protein and were often dried and ground into flour. The Wampanoag taught the settlers how to identify and prepare these wild foods, knowledge that proved crucial for survival. Fruits available would have included wild grapes, elderberries, gooseberries, and several varieties of plums. While most of these would have been past their fresh season by November, dried fruits would have been available. The drying process was sophisticated - both cultures had developed techniques to preserve fruits while maintaining their nutritive value. The preparation methods used during the feast were necessarily different from our modern techniques. Without a proper kitchen or European cooking equipment, most food would have been spit-roasted or boiled in pots. The Wampanoag brought a rich tradition of cooking techniques, including stone boiling, where heated rocks were added to wooden or hide containers to cook soups and stews. Smoking and drying were essential preservation methods that would have been actively used during the feast. Both cultures had developed sophisticated smoking techniques, though they differed in their approaches. The Wampanoag typically used cold smoking for preservation, while the English were more familiar with hot smoking. The combination of these techniques would have created unique flavors that we can only imagine today. The settlers had brought some cooking equipment from England - iron pots, spits, and possibly a few portable ovens. However, most cooking would have been done over open fires. The Wampanoag contributed their knowledge of building and maintaining different types of fires for different cooking purposes - hot fires for roasting, coals fo

First Feast Forensics (The Reality Behind The First Thanksgiving Meal)

Join our host and Inorganic Ventures Technical Director, Mike Booth, as he sparks insightful conversations with our panel of experts in Bench Boost, your go-to podcast for analytical chemistry enthusiasts. Together, they explore the realm of ICP, sharing tips and tricks and diving deep into all things analytical chemistry.

Join our host and Inorganic Ventures Technical Director, Mike Booth, as he sparks insightful conversations with our panel of experts in Bench Boost, your go-to podcast for analytical chemistry enthusiasts. Together, they explore the realm of ICP, sharing tips and tricks and diving deep into all things analytical chemistry.

Bench Boost by Inorganic Ventures

皆さん、お疲れ様です！
研究職ケロスケ氏のリアルな仕事やキャリアに迫りつつ、化学の魅力をもっと身近に感じてもらうためのトークショー！化学の現場で奮闘する“しがない研究職ケロスケ”と、“化学知識ゼロのアシスタントS”　でお送りします！

入社一年目の新人研究員のあなた！将来に悩む理系就活生のあなた！最近化学に興味をもったあなたまで！どなたでも気軽に聞ける内容となっています！

ケロスケ氏の研究職ライフを通して、「化学って意外と面白い！」と思っていただけるような番組を目指します。新しい発見やキャリアのヒントが見つかるかも！？

ぜひ、通勤・通学等のちょっとした隙間時間のお供にお楽しみください！

皆さん、お疲れ様です！ 研究職ケロスケ氏のリアルな仕事やキャリアに迫りつつ、化学の魅力をもっと身近に感じてもらうためのトークショー！化学の現場で奮闘する“しがない研究職ケロスケ”と、“化学知識ゼロのアシスタントS” でお送りします！ 入社一年目の新人研究員のあなた！将来に悩む理系就活生のあなた！最近化学に興味をもったあなたまで！どなたでも気軽に聞ける内容となっています！ ケロスケ氏の研究職ライフを通して、「化学って意外と面白い！」と思っていただけるような番組を目指します。新しい発見やキャリアのヒントが見つかるかも！？ ぜひ、通勤・通学等のちょっとした隙間時間のお供にお楽しみください！

ケロスケ氏の研究職ライフ~化学を仕事にしてみた~

Salute Magazine offre un ampio panorama sulla salute, dalla medicina alle ultime ricerche scientifiche, fino al wellness. Ogni episodio presenta interviste con esperti del settore, medici, ricercatori e professionisti, per esplorare temi legati al benessere fisico e mentale. Tra prevenzione, trattamenti innovativi, e nuovi sviluppi nel campo della medicina, il podcast ti aiuta a rimanere aggiornato sulle novità che possono migliorare la qualità della tua vita. Unisciti a noi per scoprire come le scelte quotidiane, le abitudini sane e i progressi scientifici possano fare la differenza nella tua salute.

Salute Magazine

Porque no basta con explicar la ciencia, también hay que conocer a los científicos que están detrás de ella... En este programa entrevistamos a grandes científicos de toda la Republica Mexicana con la finalidad de conocer más sobre sus líneas de investigación. Además de platicar de ciencia nuestros invitados nos comparten un poco de sus gustos musicales y de su vida fuera del laboratorio. DNA es parte de la plataforma ScienceSocks

Porque no basta con explicar la ciencia, también hay que conocer a los científicos que están detrás de ella... En este programa entrevistamos a grandes científicos de toda la Republica Mexicana con la finalidad de conocer más sobre sus líneas de investigación. Además de platicar de ciencia nuestros invitados nos comparten un poco de sus gustos musicales y de su vida fuera del laboratorio. DNA es parte de la plataforma ScienceSocks

Podcast educativo sobre Ciencias, matemática, química y física.

La tabla periódica y los elementos

Ruth Chacaguasay  IMPORTANCIA DEL ACETILENO

Ruth Chacaguasay IMPORTANCIA DEL ACETILENO

Ruth Chacaguasay&nbsp; IMPORTANCIA DEL ACETILENO

IMPORTANCIA EL ACETILENO

A special segment on Money FM 89.3's Breakfast Show that brings you on an exclusive audio journey to the ends of the world, covering in-depth environment, natural history and climate change stories that intertwine with human life on Earth.

A special segment on Money FM 89.3's Breakfast Show that brings you on an exclusive audio journey to the ends of the world, covering in-depth environment, natural history and climate change stories that intertwine with human life on Earth.

Climate Connections

applicazione del principio di Le Chatelier e l’equilibrio chimico nella vita reale

lavoro chimica

In this episode of "<a target="_blank" rel="noopener noreferrer nofollow" href="https://bhumigrowthsolutions.com/">Bhumi Growth Solutions - Pest Control Revolution</a>," we delve into the transformative power of EmaGuard 5X and how it can help farmers achieve unparalleled crop yields. With Emamectin Benzoate 5% SG at its core, EmaGuard 5X is more than just an insecticide—it's a game-changer for modern agriculture.Join us as we explore the unique features and benefits of EmaGuard 5X, from its fast-acting pest control to its long-lasting protection. Discover how its innovative water-soluble granular formulation ensures even distribution and effective pest management across a variety of crops, including cotton, chillies, cabbage, okra, and tomatoes.We'll also hear from real farmers who have experienced the incredible results of using EmaGuard 5X, boosting their crop health and productivity while promoting sustainable farming practices. Our expert guests will share practical tips on application methods, dosage recommendations, and best practices to maximize the benefits of this revolutionary product.Tune in to "Maximizing Crop Yields with EmaGuard 5X" and learn how this cutting-edge insecticide can help you unlock the full potential of your fields, ensuring healthier crops and higher yields. Don't miss this in-depth discussion on taking your farming game to the next level!

In this episode of "Bhumi Growth Solutions - Pest Control Revolution," we delve into the transformative power of EmaGuard 5X and how it can help farmers achieve unparalleled crop yields. With Emamectin Benzoate 5% SG at its core, EmaGuard 5X is more than just an insecticide—it's a game-changer for modern agriculture. Join us as we explore the unique features and benefits of EmaGuard 5X, from its fast-acting pest control to its long-lasting protection. Discover how its innovative water-soluble granular formulation ensures even distribution and effective pest management across a variety of crops, including cotton, chillies, cabbage, okra, and tomatoes. We'll also hear from real farmers who have experienced the incredible results of using EmaGuard 5X, boosting their crop health and productivity while promoting sustainable farming practices. Our expert guests will share practical tips on application methods, dosage recommendations, and best practices to maximize the benefits of this revolutionary product. Tune in to "Maximizing Crop Yields with EmaGuard 5X" and learn how this cutting-edge insecticide can help you unlock the full potential of your fields, ensuring healthier crops and higher yields. Don't miss this in-depth discussion on taking your farming game to the next level!

In this episode of "<a href="https://bhumigrowthsolutions.com/" rel="noopener noreferrer">Bhumi Growth Solutions - Pest Control Revolution</a>," we delve into the transformative power of EmaGuard 5X and how it can help farmers achieve unparalleled crop yields. With Emamectin Benzoate 5% SG at its core, EmaGuard 5X is more than just an insecticide—it's a game-changer for modern agriculture.Join us as we explore the unique features and benefits of EmaGuard 5X, from its fast-acting pest control to its long-lasting protection. Discover how its innovative water-soluble granular formulation ensures even distribution and effective pest management across a variety of crops, including cotton, chillies, cabbage, okra, and tomatoes.We'll also hear from real farmers who have experienced the incredible results of using EmaGuard 5X, boosting their crop health and productivity while promoting sustainable farming practices. Our expert guests will share practical tips on application methods, dosage recommendations, and best practices to maximize the benefits of this revolutionary product.Tune in to "Maximizing Crop Yields with EmaGuard 5X" and learn how this cutting-edge insecticide can help you unlock the full potential of your fields, ensuring healthier crops and higher yields. Don't miss this in-depth discussion on taking your farming game to the next level!

Maximizing Crop Yields with EmaGuard 5X

Prozessindustrie und Nachhaltigkeit sind keinesfalls Gegensätze, sondern zwei Seiten der gleichen Medaille. Sie ergänzen, ja sie bedingen sich vielfach. Was treibt die Verantwortlichen derzeit um? Im PROCESS-Podcast GreenTEC gehen wir dem auf den Grund und zeigen innovative, grüne Lösungen für eine nachhaltige Zukunft der Branche.

GreenTEC

Fogászati kérdéseidre keressük a választ podcastunkban. Dr. Németh József, a Nádor Dental orvos igazgatója egyszerű, közérthető nyelven magyarázza el a gyökérkezelés, implantáció, fogszabályozás és egyéb fogászati eljárások lényegét.

Fogászati kérdéseidre keressük a választ podcastunkban. Dr. Németh József, a Nádor Dental orvos igazgatója egyszerű, közérthető nyelven magyarázza el a gyökérkezelés, implantáció, fogszabályozás és egyéb fogászati eljárások lényegét.

Gondoskodó Fogászat Budapest szívében

BLAHHHtesting

Chartable Feed Testing

A veterinary specials podcast, bringing you the latest industry updates. We aim to provide an insight into Bova UK and also provide bite-sized discussions on diagnosis, treatment, and management of specific diseases or conditions.&nbsp;

A veterinary specials podcast, bringing you the latest industry updates. We aim to provide an insight into Bova UK and also provide bite-sized discussions on diagnosis, treatment, and management of specific diseases or conditions. 

Bova UK Podcast

Each podcast contains timely nutritional information from Adisseo and industry experts.&nbsp; &nbsp; The conversational Transition Health series focuses on solutions to transition health concerns.&nbsp; &nbsp; The previous two series present research highlights from the 2021 and 2022 American Dairy Science Association (ADSA) Annual Meetings.&nbsp; &nbsp; The latest serie focuses on Amino Acid balancing for Lifetime Performance as we are celebrating the 30th anniversary of AA balancing in 2023.

Each podcast contains timely nutritional information from Adisseo and industry experts.    The conversational Transition Health series focuses on solutions to transition health concerns.    The previous two series present research highlights from the 2021 and 2022 American Dairy Science Association (ADSA) Annual Meetings.    The latest serie focuses on Amino Acid balancing for Lifetime Performance as we are celebrating the 30th anniversary of AA balancing in 2023.

Smart Science Series™ Ruminant Podcasts

My name is Brad Whitley and I have been a certified pesticide applicator in Mechanicsville, Virginia USA. I will bring you reviews, news, and how-to's to the DIY exterminators and new pest control technicians.  I have found that most residents can't afford professional pest services or they want to do their own pest control, but don't know exactly how to get great result. Let me help.

My name is Brad Whitley and I have been a certified pesticide applicator in Mechanicsville, Virginia USA. I will bring you reviews, news, and how-to's to the DIY exterminators and new pest control technicians. I have found that most residents can't afford professional pest services or they want to do their own pest control, but don't know exactly how to get great result. Let me help.

My name is Brad Whitley and I have been a certified pesticide applicator in Mechanicsville, Virginia USA. I will bring you reviews, news, and how-to's to the DIY exterminators and new pest control technicians.&nbsp; I have found that most residents can't afford professional pest services or they want to do their own pest control, but don't know exactly how to get great result. Let me help.

Whitley Pest Podcast

In this podcast, we are going to highlight amazing faculty, undergraduate, graduates, and alumni of the Texas A&M Department of Chemistry.  We will interview people and ask them about the world of chemistry, recent news, and exciting topics for different people.

In this podcast, we are going to highlight amazing faculty, undergraduate, graduates, and alumni of the Texas A&M Department of Chemistry. We will interview people and ask them about the world of chemistry, recent news, and exciting topics for different people.

In this podcast, we are going to highlight amazing faculty, undergraduate, graduates, and alumni of the Texas A&amp;M Department of Chemistry.  We will interview people and ask them about the world of chemistry, recent news, and exciting topics for different people.

Chemistry Podcasts / Page 13